Elisabet
Guruceaga Martínez
Bioinformática
Instituto de Salud Carlos III
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Instituto de Salud Carlos III (9)
2024
-
Caspases compromise SLU7 and UPF1 stability and NMD activity during hepatocarcinogenesis
JHEP Reports, Vol. 6, Núm. 8
2023
-
Signature-driven repurposing of Midostaurin for combination with MEK1/2 and KRASG12C inhibitors in lung cancer
Nature Communications, Vol. 14, Núm. 1
2021
-
FOSL1 promotes cholangiocarcinoma via transcriptional effectors that could be therapeutically targeted
Journal of Hepatology, Vol. 75, Núm. 2, pp. 363-376
2020
-
A novel FTY720 analogue targets SET-PP2A interaction and inhibits growth of acute myeloid leukemia cells without inducing cardiac toxicity
Cancer Letters, Vol. 468, pp. 1-13
-
Effects of maresin 1 (MaR1) on colonic inflammation and gut dysbiosis in diet-induced obese mice
Microorganisms, Vol. 8, Núm. 8, pp. 1-16
-
Sex-specific associations between gut prevotellaceae and host genetics on adiposity
Microorganisms, Vol. 8, Núm. 6, pp. 1-19
2019
2016
-
Gene methylation parallelisms between peripheral blood cells and oral mucosa samples in relation to overweight
Journal of Physiology and Biochemistry, Vol. 73, Núm. 3, pp. 465-474
2013
-
Spanish human proteome project: Dissection of chromosome 16
Journal of Proteome Research, Vol. 12, Núm. 1, pp. 112-122